Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: September 2011
-
Management Forum and JNB Marketing & Events and will be offering a three-day course entitled "Biotechnology from the Ground Up" on November 2-4, 2011 in San Diego, CA. The course will offer presentations on the following topics: Day One• Introduction to Biotechnology• Introduction to Molecular Biology• Re-Expression of Proteins• Development of Production Organisms• Fermentation Technology…
-
By Kevin E. Noonan — Accompanying the Federal Circuit's majority decision in Classen Immunotherapies, Inc. v. Biogen IDEC is a separate explication of "additional views" by Chief Judge Rader (at right) joined by Judge Newman. These views tend towards the policy and philosophical implications of patent eligibility challenges before the Court in several cases (In re…
-
By Donald Zuhn — After considering three amendments, rejecting two and tabling a third, the Senate today voted 89 to 9 in favor of H.R. 1249, the House version of the Leahy-Smith America Invents Act. Opposing passage of the bill were Senators Barbara Boxer (D-CA), Maria Cantwell (D-WA), Tom Coburn (R-OK), Jim DeMint (R-SC), Ron…
-
By James DeGiulio — Teva's Patents Covering Copaxone Upheld in Infringement Suit Mylan failed in its efforts to dismiss Teva's patent suit over the multiple-sclerosis drug Copaxone when the patents directed to the active pharmaceutical ingredient (API) in the drug, glatiramer acetate, were upheld as valid. In September 2008, Teva brought suit in the Southern…
-
By Donald Zuhn — Earlier today, the Senate voted 93-5 to invoke cloture on a motion to proceed to H.R. 1249, the House version of the Leahy-Smith America Invents Act. Opposing the motion were Senators Tom Coburn (R-OK), Jim DeMint (R-SC), Ron Johnson (R-WI), Mike Lee (R-UT) and Rand Paul (R-KY); Senators John Rockefeller IV…
-
By Kevin E. Noonan — The Federal Circuit majority decision in Classen Immunotherapies, Inc. v. Biogen IDEC engendered a strong dissent from Judge Moore on almost every aspect of that decision. Judge Moore disagreed with the majority's opinion that the claims were patent-eligible, that the issue of inherent anticipation was not properly before the Court,…
-
By Donald Zuhn — Tomorrow, the Senate will vote to invoke cloture on a motion to proceed to H.R. 1249, the House version of the Leahy-Smith America Invents Act. The vote to invoke cloture is scheduled to take place immediately after the Senate considers Bernice Bouie Donald for U.S. Circuit Judge for the Sixth Circuit…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Par Pharmaceutical, Inc. et al. v. TWi Pharmaceuticals, Inc.1:11-cv-02466; filed September 1, 2011 in the District Court of Maryland • Plaintiffs: Par Pharmaceutical, Inc.; EDT Pharma Holdings Ltd.• Defendant: TWi Pharmaceuticals, Inc. Par Pharmaceutical, Inc.…
-
September 6-7, 2011 – Pharmaceutical Law Academy (IBC Legal Conferences) – London, UK September 8, 2011 – Patents and the Written Description Requirement: Lessons Learned Since Ariad v. Lilly (Strafford) – 1:00 – 2:30 PM (EDT) September 11-13, 2011 – 2011 Annual Meeting (Intellectual Property Owners Association) – Los Angeles, CA September 13, 2011 –…
-
Last month, the ABA Journal began work on its 5th annual list of the 100 best legal blogs (or blawgs) and announced that it is seeking the advice of its readers, via the ABAJournal.com website, on which blawgs and practice areas to include on this year's Blawg 100. Readers interested in nominating a particular blog…
Patent Docs 